The Role of Colistin in Urinary Tract Infections in the Neurologic Patient
Abstract
Urinary tract infections represent a frequent, infectious casuistry of the neurologic patient, often recurrent, with the significant involvement of multidrug-resistant bacteria (MDRs). A retrospective study, during the period 01.01.2018-31.12.2018, in the Clinical Neurology Hospital in Craiova, on a group of 334 Px with urinary tract infections and proven microbial etiology (positive urocultures), for whom antibiograms were performed using KIRBY-BAUER disk diffusion test. The duplicates and samples considered contaminated were excluded from the study. Urinary tract infections are frequently encountered in the neurologic patient, the major etiology being represented by E. coli; the risk of multidrug-resistance is not to be neglected, Klebsiella pn being the most common in such a situation.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.